Cargando…
Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET
Monoclonal antibodies (mAbs), which play a prominent role in cancer therapy, can interact with specific antigens on cancer cells, thereby enhancing the patient’s immune response via various mechanisms, or mAbs can act against cell growth factors and, thereby, arrest the proliferation of tumor cells....
Autor principal: | Kim, Jin Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870465/ https://www.ncbi.nlm.nih.gov/pubmed/27275358 http://dx.doi.org/10.1007/s13139-015-0392-7 |
Ejemplares similares
-
Immuno-PET imaging based radioimmunotherapy in head and neck squamous cell carcinoma model
por: Song, In Ho, et al.
Publicado: (2017) -
Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer
por: Wei, Weijun, et al.
Publicado: (2020) -
Combination Radioimmunotherapy Strategies for Solid Tumors
por: Zaheer, Javeria, et al.
Publicado: (2019) -
Immuno-PET for Clinical Theranostic Approaches
por: Bailly, Clément, et al.
Publicado: (2016) -
Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy
with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios
por: Suzuki, Hiroyuki, et al.
Publicado: (2021)